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http://ccforum.com/content/18/3/436CORRECTIONCorrection: The effect of glutamine therapy on
outcomes in critically ill patients: a meta-analysis
of randomized controlled trials
Qi-Hong Chen1, Yi Yang1, Hong-Li He1, Jian-Feng Xie1, Shi-Xia Cai1, Ai-Ran Liu1, Hua-Ling Wang2 and Hai-Bo Qiu1*See related research by Chen et al., http://ccforum.com/content/18/1/R8After publication of our article in a recent issue of Critical
Care [1], inconsistencies were identified in Figure 6. Four tri-
als - by Fuentes-Orozco and colleagues [2,3], Hall and col-












Heterogeneity: Chi² = 6.25, df = 7 (P = 0.51); I² = 0%
Test for overall effect: Z = 0.62 (P = 0.53)








Heterogeneity: Chi² = 4.24, df = 4 (P = 0.38); I² = 6%








Heterogeneity: Chi² = 3.91, df = 3 (P = 0.27); I² = 23%
Test for overall effect: Z = 2.48 (P = 0.01)
Total (95% CI)
Total events
Heterogeneity: Chi² = 19.23, df = 16 (P = 0.26); I² = 17%
Test for overall effect: Z = 1.26 (P = 0.21)
















































































































Figure 1 A subgroup meta-analysis of the effects of different dosages o
CI, confidence interval; M-H, Mantel-Haenszel.
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unless otherwise stated.the wrong subgroup in our meta-analysis. They should have
been included in the first subgroup (glutamine <0.3 g/kg per
day); this does not change the significance of the results
(P=0.01). The correct Figure 6 is given here in full as Figure 1.%
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f glutamine on mortality in critically ill patients (fixed effects models).
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